Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02584270 · ClinicalTrials.gov registry record · NA
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
A NA study of Oral Cancer and Tongue Cancer, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02584270: Recruiting NA study of Oral Cancer and Tongue Cancer, sponsored by University of Michigan.
NCT02584270 is a NA study of Oral Cancer and Tongue Cancer that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 40 participants, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02584270, a NA study of Oral Cancer and Tongue Cancer, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis (PAP) as a therapeutic modality post-surgery. This is a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential to dramatically alter the most common issues of oral cancer therapy, namely speech and swallowing functions. Patients will have been diagnosed with a cancer lesion of the tongue requiring surgery and removal of part of the tongue. Smaller cancers of the tongue are sized as T1 or T2. For patients with smaller lesions, a PAP, which can aid in speaking and swallowing, is not routinely provided.
Primary Outcome
The Assessment of Intelligibility of Dysarthric speech (AIDS) test is a validated assessment of word and sentence intelligibility as well as speech efficiency. The AIDS score will be measured at baseline before surgery for tongue cancer, then after surgery at the timepoints of one month, three months, six months and one year. Six months is the primary time point measurement. Measurements will also be obtained at these other time points, which will possibly be used for other outcome analysis whic
Conditions Studied
Interventions
- DEVICE Palatal Augmentation Prosthesis (PAP)
- OTHER Articulation Therapy
Study Locations (1)
Michigan
- University of Michigan Department of Oral and Maxillofacial Surgery and Hospital Dentistry - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT02584270 shows while recruiting
NCT02584270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Oral Cancer appearing as the primary indexed condition, and to 2 interventions - of which Palatal Augmentation Prosthesis (PAP) is the first listed.
NCT02584270 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02584270 about?
NCT02584270 is a clinical study titled "Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue". This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis (PAP) as a therapeutic modality post-surgery. This is a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential t...
What is the current status of trial NCT02584270?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-01-02. Estimated completion is 2026-06.
What conditions does trial NCT02584270 study?
This clinical trial studies the following conditions: Oral Cancer, Tongue Cancer, Tongue Neoplasms.
What interventions are being tested in trial NCT02584270?
The interventions under investigation include: Palatal Augmentation Prosthesis (PAP) (DEVICE), Articulation Therapy (OTHER).
Who is sponsoring clinical trial NCT02584270?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02584270 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oral Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02584270's enrollment target sits among peer trials
40 12th of 17 higher than 4 of 17 other Oral Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oral Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
RECRUITING · NA
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
RECRUITING · NA
-
Enhancing Oral Cancer Awareness
RECRUITING · NA
-
Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial
ACTIVE NOT RECRUITING · NA
-
Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI